Evorpacept Active Not Recruiting Phase 2 Trials for Squamous Cell Carcinoma of the Head and Neck (SCCHN) / Head And Neck Cancer Treatment

Indications	Status	Purpose	Phase
DBCOND0035874 (Squamous Cell Carcinoma of the Head and Neck (SCCHN)) DBCOND0042625 (Head And Neck Cancer)	Active Not Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT04675333	Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)	Carboplatin (DB00958) Cisplatin (DB00515) Evorpacept (DB17573) Fluorouracil (DB00544) Pembrolizumab (DB09037)
NCT04675294	Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)	Evorpacept (DB17573) Pembrolizumab (DB09037)